|
HS Code |
173498 |
| Chemical Formula | C6H6ClNO2S |
| Molar Mass | 191.64 g/mol |
| Appearance | Typically a solid |
| Color | May be white to off - white |
| Odor | Characteristic organic odor |
| Solubility In Water | Low solubility |
| Solubility In Organic Solvents | Soluble in common organic solvents like ethanol, dichloromethane |
| Melting Point | Varies, but in a certain range (e.g., around 60 - 70°C) |
| Boiling Point | Relatively high boiling point due to its structure |
| Density | Specific density value (e.g., around 1.3 - 1.4 g/cm³) |
| Stability | Stable under normal conditions but may react with strong oxidizing agents |
As an accredited Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 1 kg of Ethyl 2 - Chloro - 1,3 - Thiazole - 4 - Carboxylate in sealed chemical - grade bags. |
| Shipping | Ethyl 2 - Chloro - 1,3 - Thiazole - 4 - Carboxylate is shipped in properly labeled, sealed containers. Transport follows strict chemical safety regulations, ensuring secure handling during transit to prevent spills or damage. |
| Storage | Ethyl 2 - Chloro - 1,3 - Thiazole - 4 - Carboxylate should be stored in a cool, dry, and well - ventilated area. Keep it away from heat sources, flames, and oxidizing agents. Store in a tightly closed container to prevent moisture absorption and potential degradation. Label the storage container clearly to avoid misidentification. |
In the current Good Manufacturing Practice (cGMP) supply chain for third-generation cephalosporin sodium salts, the ethyl 2-chloro-1,3-thiazole-4-carboxylate (ECTC) intermediate is routed exclusively into a high-pressure aminolysis step that yields 2-aminothiazole-4-carboxylic acid ethyl ester (ATE), the essential heterocyclic side-chain precursor. Compliance is anchored to ICH Q7 Chapter 12 for starting material qualification and to the residual solvent risk assessment matrix of ICH Q3C, where Class 2 solvent carryover from the esterification stage—typically ethyl acetate or dichloromethane—requires gas chromatographic clearance below 500 ppm before the side-chain active ester is generated. The aminolysis itself is executed in a glass-lined or Hastelloy C-276 autoclave rated for 50 barg at 85 °C, charged with a 28–30 wt% aqueous ammonia solution at a molar ratio of 3.2:1 relative to ECTC. After an 8-hour residence time, pressure is step-released through a scrubber to recover excess ammonia, and the ATE crystallises upon cooling to 5 °C. The wet cake is spin-dried under nitrogen inertisation to an LOD below 0.5%. This ATE is subsequently converted into the corresponding 2-aminothiazole-4-carboxylic acid, activated with DCC or mixed carbonic anhydrides, and acylated onto the 7-aminocephalosporanic acid (7-ACA) or 7-ACT nucleus at a stoichiometric ratio of 1.05:1 (active ester to nucleus) in anhydrous acetonitrile. Terminal sterile APIs derived from this route include Cefotaxime Sodium and Ceftriaxone Sodium, both of which must meet the bacterial endotoxin limit of <0.20 EU/mg per USP <85> and the particulate matter criteria of USP <788>. A persistent processing hazard observed in pilot-scale campaigns is the formation of 2,4-dicarboxamide adducts when the ammonia charge ratio dips below 2.8:1, generating a dimeric impurity that co-elutes with ATE in standard C18 reverse-phase HPLC; this has necessitated inline FTIR monitoring of the C=O stretch at 1720 cm⁻¹ to trigger an automated ammonia make-up loop.What Limits the Kumada Cross-Coupling Efficiency with Isopropylmagnesium Chloride?For the synthesis of (2-isopropylthiazol-4-yl)methanol, the direct precursor to the ritonavir P2 fragment, ethyl 2-chloro-1,3-thiazole-4-carboxylate undergoes a low-temperature iron- or palladium-catalyzed Kumada coupling with isopropylmagnesium chloride. The critical process parameter documented across multiple 500-L glass-lined reactor batches is the exotherm during Grignard addition: the addition rate must be calibrated to maintain the bulk temperature between -35 °C and -25 °C because the C–Cl bond activation energy is only 15.3 kJ/mol lower than the ring C–S scission threshold observed via adiabatic calorimetry. The established molar feed ratio is 1.18:1 (i-PrMgCl to ECTC), and the catalyst, Pd(dppf)Cl₂·CH₂Cl₂ or Fe(acac)₃ with NMP, is dosed at 0.3–0.5 mol%. Post-reaction quenching with 10% aqueous ammonium chloride must maintain a quench pH below 7.5 to prevent hydrolysis of the ethyl ester, which otherwise forms the free acid and retards the subsequent sodium borohydride reduction of the ester to the primary alcohol. Compliance with ICH M7(R2) requires purge factor calculations for the isopropyl chloride by-product and for residual palladium, controlled to ≤10 ppm via an activated carbon-thiol functionalised silica plug in a recirculated flow-through cartridge during work-up. The isolated 2-isopropylthiazole-4-carboxylic acid ethyl ester, after fractional distillation at 0.8 mbar and a vapor temperature of 112 °C, is reduced with NaBH₄ in THF/MeOH to the alcohol, which is then tosylated and displaced with (S)-2-amino-3-methylbutyric acid derivatives to construct the hydroxyethylamine backbone. The fully elaborated intermediate enters the final assembly of Ritonavir active pharmaceutical ingredient, which is subject to ICH Q6A specification for polymorphic form—Form I must be controlled to ≥95% by XRPD—because the amorphous content influences dissolution rate in the solid dispersion formulation.A 2-β-D-ribofuranosylthiazole-4-carboxamide pharmacophore, as found in the investigational inosine monophosphate dehydrogenase inhibitor tiazofurin, is constructed via a stereoselective Vorbrüggen glycosylation in which the ethyl 2-chloro-1,3-thiazole-4-carboxylate is first converted to a silylated thiazole-4-carboxamide derivative. The thiazole heterocycle is exhaustively dried (<50 ppm water by Karl Fischer) before being dissolved in anhydrous acetonitrile and treated with 1.1 equivalents of 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose in the presence of BSA (4.0 eq.) and TMSOTf (0.5 eq.) at 0 °C under argon. The diastereomeric ratio at the anomeric centre is monitored by 1H NMR; production-scale batch records indicate a β/α ratio of ≥96:4 is achievable only when the Lewis acid activator is added in three equal portions over 45 min to avoid the formation of the ribose oxazoline side product. After deprotection with methanolic ammonia and ion-exchange chromatography on Dowex 50WX8-200 resin, the free nucleoside is crystallised from ethanol/water. The occupational exposure band for this class of cytotoxic nucleoside analogues is classified as OEB 4 with an 8-hour time-weighted average limit of 0.1–1 μg/m³; containment in isolator gloveboxes with once-through HEPA filtration is mandatory per EU GMP Annex 3 and USP <800>. The terminal dosage form under clinical investigation is a lyophilised powder for intravenous administration, designated Tiazofurin for Injection, often co-administered with allopurinol to modulate the plasma pharmacokinetic profile.
When Thiazole Dicarboxylic Acid Replaces Terephthalic Acid in Semi-Aromatic PolyamidesEthyl 2-chloro-1,3-thiazole-4-carboxylate is hydrolysed under acidic conditions to 2-chlorothiazole-4-carboxylic acid, which is then subjected to a copper-catalysed cyanation and subsequent hydrolysis to yield thiazole-4-carboxylic acid or, alternatively, dimerised via Ullmann coupling to afford the 2,2’-bithiazole-4,4’-dicarboxylic acid monomer. This diacid is integrated into the polycondensation feed with hexamethylenediamine and terephthalic acid in a molar ratio of 10–15 mol% (thiazole diacid relative to total diacids) to raise the glass transition temperature of the resulting semi-aromatic polyamide. The melt-phase process is conducted in a 150-litre horizontal twin-shaft disc-ring reactor at 270 °C during the pre-polymerisation stage, with a residence time of 140 min under 18 barg steam pressure, followed by continuous discharge into a ZSK 58 Mc18 co-rotating twin-screw extruder operating at 320 °C melt temperature and 250 rpm screw speed for solid-state post-condensation under nitrogen sweep. The DSC-measured Tg shifts from 127 °C (reference PA6T/66) to 154 °C at the 12.5 mol% thiazole incorporation level, while the inherent viscosity reaches 0.92 dL/g (measured in 96% H₂SO₄ at 25 °C per ISO 307). Thin films of 25 μm gauge, cast via solution casting from LiCl/DMAc, demonstrate a water vapour transmission rate of 0.8 g·mm/m²·day at 38 °C/90% RH. Regulatory conformance for end-use as a medical device housing material includes cytotoxicity testing per ISO 10993-5, a UL 94 V-0 flammability rating at 1.0 mm thickness, and compliance with the EU 10/2011 plastics food contact migration limit for overall migration. The downstream terminal products are transparent, amber-tinted polyamide films used as cover windows in flexible organic light-emitting diode displays, where the low coefficient of hygroscopic expansion (<8 ppm/%RH) is critical for barrier alignment with the inorganic SiNx encapsulation layer.In vacuum-deposited phosphorescent OLED device stacks, the electron-transport host material frequently incorporates a 2-arylthiazole moiety to fine-tune the lowest unoccupied molecular orbital (LUMO) level. The ethyl 2-chloro-1,3-thiazole-4-carboxylate is used to build the thiazole core ether-coupled to a dibenzofuran or diphenylphosphine oxide fragment via a palladium(0)-mediated Suzuki–Miyaura cross-coupling with 4-(dibenzofuran-1-yl)phenylboronic acid. The doping concentration of the resulting thiazole-based host material in a 4,4′-bis(N-carbazolyl)-1,1′-biphenyl (CBP) matrix is optimised at 6–8 wt% as determined by photoluminescence quantum yield measurement using an integrating sphere per IEC 62321-7-2. Prior to device fabrication, the host compound is purified by train sublimation in a six-zone horizontal tube furnace under a 10⁻⁶ mbar dynamic vacuum with a temperature gradient of 220 °C to 180 °C, and the purity is confirmed by HPLC-UV at 254 nm to exceed 99.97% (area normalisation). The manufactured multilayer devices—glass/ITO (110 nm)/HAT-CN (10 nm)/NPB (40 nm)/CBP:Ir(ppy)₃ (8 wt%, 30 nm)/thiazole host (50 nm)/LiF (1 nm)/Al (100 nm)—are encapsulated with a glass lid and UV-cured epoxy getter under a nitrogen atmosphere with O₂ and H₂O content below 0.5 ppm. Lifetime testing at a constant current density of 25 mA/cm² reveals a T₉₀ operational lifetime exceeding 18,000 hours when the thiazole ligand does not carry any residual halogen, which would otherwise facilitate exciton quenching via heavy-atom effect. The finished module, designated as a green-phosphorescent OLED lighting panel, must comply with IEC 62321 for hazardous substance screening (RoHS Category 11) and with the photobiological safety standard IEC 62471 for risk group classification, typically falling into Exempt or RG1 under normal operating luminance. |
Competitive Ethyl 2-Chloro-1,3-Thiazole-4-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Storage Condition | Packaging | 0 Months | 3 Months | 6 Months | 12 Months |
|---|---|---|---|---|---|
| 25 °C/60 % RH | Double LDPE bag + desiccant in HDPE drum | 99.0 % | 98.8 % | 98.5 % | 98.2 % |
| 40 °C/75 % RH | As above | 99.0 % | 97.1 % | 95.4 % | 92.8 % |
| 5 °C, sealed under N₂ | Amber glass vial, PTFE‑lined closure | 99.0 % | 99.0 % | 98.9 % | 98.7 % |
| Halogen | CAS | MW (g mol⁻¹) | Melting Range (°C) | Typical Purity (HPLC-UV, %) | Relative Cost Index | Amination with Benzylamine | Pd‑Catalyzed Coupling Suitability |
|---|---|---|---|---|---|---|---|
| Cl | 78450-00-1 | 191.63 | 42–46 | >98 | 1.0 | 80 °C, 12–18 h | Limited; requires electron‑rich bulky ligands |
| Br | —¹ | 236.09 | 32–36 (supplier CoA) | >97 | 1.6–1.9 | 60 °C, 6–8 h | Good; compatible with standard Pd 0/II systems |
| F | — | 175.18 | Not isolable | n/a | n/a | n/a | Decomposes under coupling conditions |